Dual phagocytosis-checkpoint blockade revitalizes immune surveillance in mouse models of glioblastoma

Macrophage-mediated phagocytosis of tumor cells elicits potent antitumor immunity. Nonetheless, sole-blockade of the anti-phagocytosis molecule CD47 has yielded insufficient therapeutic outcomes. Here, we report that glioblastoma (GBM) cells expressed abundant levels of phagocytosis checkpoint CD24. We further show that dual blockade of CD24 and CD47 synergistically enhances the pro-phagocytic activity of macrophages, thereby improving tumor antigen cross-presentation and activating the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway. This innate immune activation facilitates T cell infiltration into tumors and sensitizes tumors to anti-PD1 therapy, improving survival outcomes in murine GBM models, including immunosuppressive tumors reflecting human GBM-like features. Thus, our results indicate that dual-phagocytosis checkpoint blockade offers a promising therapeutic avenue to potentiate cancer immunotherapy.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2026-03-09
DOI
https://doi.org/10.1038/s41467-026-70221-9
Primary Topic
Phagocytosis and Immune Regulation
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dual phagocytosis-checkpoint blockade revitalizes immune surveillance in mouse models of glioblastoma

Mylin A. Torres, Maurice Dufilho, Ian E. McCutcheon, Weiye Deng et al.
Nature Communications
Phagocytosis and Immune Regulation
article

Dual phagocytosis-checkpoint blockade revitalizes immune surveillance in mouse models of glioblastoma

Mylin A. Torres, Maurice Dufilho, Ian E. McCutcheon, Weiye Deng, Seong Dong Jeong, Chibawanye Ene, Kadir C. Akdemir, Adam Grippin, Vinay K. Puduvalli, Benjamin R. Schrank, Shiyan Dong, Jeffrey S. Weinberg, Sherise Desiree Ferguson, Annette Wu, Sangeeta Goswami, Sonali Jindal, Yifan Ma, Sreyashi Basu, Kristin Michelle Huntoon, Padmanee Sharma, JongHoon Ha, Yifan Wang, Yen-Tzu Chang, Frederick F. Lang, Shannon McCabe, Mengyu Chang, Jared L. Edwards, Sujit Prabhu, Jian Hu, Xiaotian Wang, Shaan M. Raza, Wen Jiang, Betty Y. S. Kim, Franco DeMonte
article en

Abstract

Macrophage-mediated phagocytosis of tumor cells elicits potent antitumor immunity. Nonetheless, sole-blockade of the anti-phagocytosis molecule CD47 has yielded insufficient therapeutic outcomes. Here, we report that glioblastoma (GBM) cells expressed abundant levels of phagocytosis checkpoint CD24. We further show that dual blockade of CD24 and CD47 synergistically enhances the pro-phagocytic activity of macrophages, thereby improving tumor antigen cross-presentation and activating the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway. This innate immune activation facilitates T cell infiltration into tumors and sensitizes tumors to anti-PD1 therapy, improving survival outcomes in murine GBM models, including immunosuppressive tumors reflecting human GBM-like features. Thus, our results indicate that dual-phagocytosis checkpoint blockade offers a promising therapeutic avenue to potentiate cancer immunotherapy.

Nature Communications
The University of Texas MD Anderson Cancer Center (US), University of Arizona (US)
Break Through Cancer, National Institutes of Health
Good health and well-being
Openalex Percentile: Top 29%
Phagocytosis and Immune Regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.